You are here

Distribution Could Determine Winners in Recreational Cannabis Market -- CFN Media

SEATTLE, WA, Sept. 12, 2018 (GLOBE NEWSWIRE) -- via NEWMEDIAWIRE – CFN Media Group (“CFN Media”), the leading agency and financial media network dedicated to the North American cannabis industry, announces publication of an article discussing The Supreme Cannabis Company (TSX-V: FIRE) (OTCQX: SPRWF) (FRA: 53S1).

The Canadian adult-use cannabis market is set to launch in just over a month, on October 17, 2018. Deloitte projects the domestic cannabis market has the potential to reach C$22.6 billion over the coming years. As such, it is not surprising that an increasing number of prospective companies are looking to enter the space – already there are more than 100 licensed producers approved by Health Canada, and there are more in the pipeline.  

This obviously raises questions about the supply situation in the market. As a result, investors have recently turned their focus to distribution agreements or “off-take” in assessing the prospects for cannabis companies. Industry leader Canopy Growth has been leading the discussion in this area with its “Distribution Drives Revenue, Capacity Alone Does Not” narrative.   

Key Indicators of Success

Canadian cannabis companies offer a unique valuation challenge. Their current financial picture represents their participation in the country’s legal medical cannabis market – a sizable but still relatively small market compared to the domestic illicit recreational market.  Yet, with the flip of a “legislative switch” on October 17, these cannabis companies have access to an existing and massive potential end market – with distribution being facilitated by the government. So how do you try to value these cannabis companies given this catalyst?   

For some time, one of the key indicators investors have used in the cannabis space is the concept of funded capacity—effectively how much cannabis they can grow. The logic being the more you grow, the more you will make. Funded capacity has been a fair measure in absence of more tangible revenue and earnings estimates.

Provincial Supply Agreements to Drive Revenue

However, at this point, almost all of the provinces have announced supply agreements with various licensed producers – setting out who will have product on “shelves” on October 17 and providing insight to who will be generating revenue come legalization.        

The licensed producers that don’t have their products on the shelf when the doors open in October will face a steep challenge moving forward — the shelf will be largely “filled” across the country and for a new product to be listed, it will have to ‘bump’ out an existing product – no easy task as the liquor industry, where product turnover tends to be low, would suggest.  

At the same time, the first-movers that are on store shelves could have a significant advantage. They will have an opportunity to establish their brands, fine-tune existing product offerings, and leverage recreational market revenue to pursue other opportunities, whether fortifying and expanding their domestic market positioning or pursuing global opportunities. Only a select handful of companies have signed supply agreements with more than half the provinces, including industry leaders: Canopy Growth Corp., Aurora Cannabis Inc, Aphria Inc., and Tilray.  

Many of these companies are large and well-known names in the space, but there are a few other companies in the mix. The Supreme Cannabis Company and Organigram Holdings Inc. have both secured six supply agreements with Canadian provinces, while CannTrust Holdings has secured five supply agreements. These companies have a similar national presence as the more recognizable competitors, but have much lower market capitalizations.

Investment Opportunities

Companies like The Supreme Cannabis Company Organigram Holdings Inc. have broad distribution across Canadian provinces and more attractive market capitalizations than their more recognizable competitors.

With a market cap of just over C$500 million and C$800 million, respectively, The Supreme Cannabis Company and Organigram Holdings trade at a fraction of the market capitalization of the industry majors, despite their strong distribution footprint, solid sales in  medical channels, and strong management teams.

The Supreme Cannabis Company, in particular, has generated significant activity in recent weeks as they establish themselves as the only major licensed producer focused exclusively on premium brands and products and with coast-to-coast distribution. It is worth noting that on September 10, they announced they had entered into a supply agreement with Tilray – another positive indicator they have been successful in establishing themselves as the one of the premium brands in the market.

The Supreme Cannabis Company has not reported its fourth quarter and fiscal year-end financial results for the period ended June 30, 2018 yet, investors may want to watch closely for those results.

For more information, visit the company’s website at

Please follow the link to read the full article:


The above article is sponsored content. Emerging Growth LLC, which owns and CFN Media, has been hired to create awareness. Please follow the link below to view our full disclosure outlining our compensation:

About CFN Media

CFN Media (CannabisFN) is the leading agency and financial media network dedicated to the global cannabis industry, helps companies operating in the space attract investors, capital, and publicity. Since 2013, private and public cannabis companies in the US and Canada have relied on CFN Media to grow and succeed.

Learn how to become a CFN Media client company, brand or entrepreneur:

Download the CFN Media iOS mobile app to access the world of cannabis from the palm of your hand:

Or visit our homepage and enter your mobile number under the Apple App Store logo to receive a download link text on your iPhone:

Disclaimer is not an independent financial investment advisor or broker-dealer. You should always consult with your own independent legal, tax, and/or investment professionals before making any investment decisions. The information provided on (the ‘Site’) is either original financial news or paid advertisements drafted by our in-house team or provided by an affiliate., a financial news media and marketing firm enters into media buys or service agreements with the companies that are the subject of the articles posted on the Site or other editorials for advertising such companies.  We are not an independent news media provider. We make no warranty or representation about the information including its completeness, accuracy, truthfulness or reliability and we disclaim, expressly and implicitly, all warranties of any kind, including whether the Information is complete, accurate, truthful, or reliable. As such, your use of the information is at your own risk. Nor do we undertake any obligation to update the items posted. received compensation for producing and presenting high quality and sophisticated content on along with financial and corporate news.  

The above article is sponsored content. Emerging Growth LLC, which owns and CFN Media, has been hired to create awareness. Please follow the link below to view our full disclosure outlining our compensation:

CONTACT: Frank Lane
Wednesday, September 12, 2018 - 09:00